| Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524742 |
NSE Symbol : CAPLIPOINT |
P/E(TTM) : 41.66 |
|
ISIN Demat : INE475E01026 |
Div & Yield% : 0.35 |
EPS(TTM) : 55.22 |
|
Book Value(₹) : 269.76 |
Market Cap(₹Cr) : 17,484.21 |
Face Value(₹) : 2.00 |
| Board Of Directors | |
|---|---|
| Additional Director |
K C John
|
| Chairman & Non Executive Dir. |
C C Paarthipan
|
| Co. Sec. / Comp. Officer / General Counsel |
VENKATRAM GANAPATHYSUBRAMANIAN
|
| Independent Non Exe. Director |
R Vijayaraghavan
C K Gariyali
Deenadayalan Singaram
R Nagendran
|
| Non Independent Executive Director / MD |
Sridhar Ganesan
|
| Vice Chairman & Additional Dir |
ASHOK GORKEY PARTHEEBAN
PARTHEEBAN VIVEK SIDDARTH
|
| Whole Time Director |
D. Muralidharan
|
